#98, Advancing Adaptive Clinical Trials with Causal ML, with Raviv Pryluk from PhaseV

Sword Health's AI-powered platform offers remote monitoring, virtual PT sessions, behavioral health support, and personalized care plans for treating chronic pain.

Rune Labs leverages real-world data and digital biomarkers to revolutionize the treatment of neurodegenerative diseases like Parkinson's, enabling personalized and data-driven care.

Anterior is transforming healthcare with AI that understands clinical jargon, delivering value by automating administrative tasks like prior authorization that cost over $1 trillion annually.

Leveraging an AI-powered immune profiling platform, IMU Biosciences creates unprecedented insights into health and disease by measuring and analyzing the immune system at an unparalleled scale and resolution.

Proprio's proprietary platform provides surgeons with insightful, responsive information in the operating room, aiming to significantly improve patient outcomes and surgeon wellbeing by enhancing surgical performance and precision.

Relation leverages single-cell multi-omics, functional assays, and machine learning to better characterize diseases and develop transformational medicines.

Automata's LINQ platform integrates lab instruments, robotics, and cloud software to streamline scientific workflows and accelerate drug discovery research.

Perspectum enables non-invasive "virtual biopsies" that provide safer, more accessible disease monitoring for conditions like liver disease, diabetes, and cancer.

Happiest Baby's SNOO Smart Sleeper is an FDA-approved cradle that tracks baby's sleep, sends alerts, and automatically soothes with womb-like motions.

PhaseV is pioneering the use of reinforcement learning, causal ML, and adaptive trial design to optimize resource utilization and time efficiency in drug development.